Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
While AI tools have shown promise in reducing false positives and aiding radiologists, large prospective trials are now exploring how technology should be integrated in screening programmes
Evidence for efficacy is based on the results from the CHECKMATE-8HW study
This updated CPG and accompanying supplement represent a useful tool for a more uniform approach to the management of PTCL. They cover clinical features, histopathological diagnosis, imaging, staging and risk assessment, treatment and follow-up, and were developed by a multidisciplinary group of experts from different institutions and countries.
ESMO continues its commitment to gender-diverse and sex-specific oncology to address the growing need to close knowledge gaps among oncologists
Published online: 8 May 2025 - Annals of Oncology
d’Amore F, Federico M, de Level L, et al., on behalf of the ESMO Guidelines Committee
New indication concerns a combination with etoposide and platinum chemotherapy for the first-line treatment of adult patients with extensive-stage SCLC
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.
